CClinicalTrials.gg
Status unknownNCT05370248Updated May 11, 2022

The Effect of 6 ml/kg vs 10 ml/kg Tidal Volume on Diaphragm Dysfunction in Critically Mechanically Ventilated Patient

An interventional study of Tidal volume 6 ml/kg and Tidal volume 10 ml/kg in Mechanical Ventilation Complication, sponsored by Dr Cipto Mangunkusumo General Hospital. Status unknown at 1 site in Indonesia. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2022-05-11.

Sponsored by Dr Cipto Mangunkusumo General Hospital · Not applicable, Interventional, and Other

The sponsor has not verified this record recently (last verified May 2022), so the status shown — last known as Active, not recruiting — may be out of date.

From the registry’s dates

  • Registered 7 months after the study started (first participant enrolled Sep 2021, registered Apr 2022).
Phase
Not applicable
Study type
Interventional
Enrollment
44
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This is a randomized clinical trial to measure the effect of tidal volume (group 6 ml/kg vs 10 ml/kg) on diaphragm dysfunction on mechanically ventilated critical patient.

Read the detailed description

Patient was enrolled in the first day receiving mechanical ventilation in ICU. Patient was included to group A or group B. Group A patient will receive tidal volume of 6 ml/kg and group B patient will receive tidal volume of 10 ml/kg. The assignment was randomized. Followed for 3 days. After 24, 48, and 72 hours, patient blood will be collected to measure the interleukin value, and diaphragm dysfunction will be observed by the use of ultrasonography by expert doctor from radiology department. Data will be analyzed statistically if there is an effect of tidal volume difference on diaphragm dysfunction and interleukin-6 as marker of inflammation. The minimal sample of patient is 44 patients.

02

Conditions studied

  • Mechanical Ventilation Complication

Keywords

  • Mechanical ventilation
  • Diaphragm dysfunction
03

In context

Lead sponsor

Dr Cipto Mangunkusumo General Hospital is the lead sponsor of 37 studies on the registry; 7 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Minimum age 18 years old
  • Critically ill patients

Exclusion criteria

Exclusion Criteria:

  • Patient with ARDS (PaO2/FiO2 \<200)
  • Pregnant woman
  • Patient with history of cardiac or thorax surgery 14 days prior to admission
  • Patient with severe peripheral musculoskeletal conditions
  • Patient with prolonged in-hospital stay (>2 weeks) in the last 3 months
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
44 participants (estimated)

Study arms

  • Experimental
    The six

    The group who received tidal volume of 6 ml/kg from mechanical ventilation

    Other: Tidal volume 6 ml/kg

  • Active comparator
    The ten

    The group who received tidal volume of 10 ml/kg from mechanical ventilation

    Other: Tidal volume 10 ml/kg

Interventions

  • OtherTidal volume 6 ml/kg

    Tidal volume is defined as the amount of air that moves in or out of the lungs with each respiratory cycle, given by the mechanical ventilator.

  • OtherTidal volume 10 ml/kg

    Tidal volume is defined as the amount of air that moves in or out of the lungs with each respiratory cycle, given by the mechanical ventilator.

06

What researchers measure

Primary outcomes

  1. DD-24

    Diaphragm dysfunction 24 hours after mechanical ventilation assessed by ultrasound.

    Time frame: 24 hours after mechanical ventilation

  2. DD-48

    Diaphragm dysfunction 48 hours after mechanical ventilation assessed by ultrasound.

    Time frame: 48 hours after mechanical ventilation

  3. DD-72

    Diaphragm dysfunction 72 hours after mechanical ventilation assessed by ultrasound.

    Time frame: 72 hours after mechanical ventilation

Secondary outcomes

  1. IL-6-24

    Blook interleukin 6 24 hours after mechanical ventilation

    Time frame: 24 hours after mechanical ventilation

  2. IL-6-48

    Blook interleukin 6 48 hours after mechanical ventilation

    Time frame: 48 hours after mechanical ventilation

  3. IL-6-72

    Blook interleukin 6 72 hours after mechanical ventilation

    Time frame: 72 hours after mechanical ventilation

Other outcomes

  1. Discharge outcome

    The outcome at hospital discharge (alive or death)

    Time frame: Up to three months after mechanical ventilation

  2. LOS in hospital

    Length of stay (days) in hospital

    Time frame: Up to three months after mechanical ventilation

  3. LOS in ICU

    Length of stay (days) in ICU

    Time frame: Up to three months after mechanical ventilation

  4. Weaning failure

    The condition where patient failed for spontaneous breathing trial after mechanical ventilation. Grouped into success/failed.

    Time frame: Up to three months after mechanical ventilation

  5. Intubation time

    Time (hours) long when a patient was intubated

    Time frame: At extubation after mechanical ventilation

07

Study locations

1 site
  • Dr Cipto Mangunkusumo Hospital
    Jakarta Pusat, DKI Jakarta 10430, Indonesia
08

References and documents

Publications

  • Mehta AB, Syeda SN, Wiener RS, Walkey AJ. Epidemiological trends in invasive mechanical ventilation in the United States: A population-based study. J Crit Care. 2015 Dec;30(6):1217-21. doi: 10.1016/j.jcrc.2015.07.007. Epub 2015 Jul 16. PubMed 26271686 ↗
  • Tremblay LN, Slutsky AS. Ventilator-induced lung injury: from the bench to the bedside. Intensive Care Med. 2006 Jan;32(1):24-33. doi: 10.1007/s00134-005-2817-8. Epub 2005 Oct 18. No abstract available. PubMed 16231069 ↗
  • Brochard L, Slutsky A, Pesenti A. Mechanical Ventilation to Minimize Progression of Lung Injury in Acute Respiratory Failure. Am J Respir Crit Care Med. 2017 Feb 15;195(4):438-442. doi: 10.1164/rccm.201605-1081CP. PubMed 27626833 ↗
  • Petrof BJ. Diaphragm Weakness in the Critically Ill: Basic Mechanisms Reveal Therapeutic Opportunities. Chest. 2018 Dec;154(6):1395-1403. doi: 10.1016/j.chest.2018.08.1028. Epub 2018 Aug 23. PubMed 30144420 ↗
  • Supinski GS, Morris PE, Dhar S, Callahan LA. Diaphragm Dysfunction in Critical Illness. Chest. 2018 Apr;153(4):1040-1051. doi: 10.1016/j.chest.2017.08.1157. Epub 2017 Sep 5. PubMed 28887062 ↗
  • Demoule A, Jung B, Prodanovic H, Molinari N, Chanques G, Coirault C, Matecki S, Duguet A, Similowski T, Jaber S. Diaphragm dysfunction on admission to the intensive care unit. Prevalence, risk factors, and prognostic impact-a prospective study. Am J Respir Crit Care Med. 2013 Jul 15;188(2):213-9. doi: 10.1164/rccm.201209-1668OC. PubMed 23641946 ↗
  • Zambon M, Greco M, Bocchino S, Cabrini L, Beccaria PF, Zangrillo A. Assessment of diaphragmatic dysfunction in the critically ill patient with ultrasound: a systematic review. Intensive Care Med. 2017 Jan;43(1):29-38. doi: 10.1007/s00134-016-4524-z. Epub 2016 Sep 12. PubMed 27620292 ↗
  • Moxham J, Goldstone J. Assessment of respiratory muscle strength in the intensive care unit. Eur Respir J. 1994 Nov;7(11):2057-61. PubMed 7875282 ↗

Individual participant data

Plan to share: No — IPD will not be shared since it is belong to the hospital and patient did not consent it to be published.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 11, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05370248
Lead sponsor
Dr Cipto Mangunkusumo General Hospital
Responsible party
Darma Putra Sitepu (Anesthesiologist Consultant In-Training, Principal Investigator, Dr Cipto Mangunkusumo General Hospital) — Principal investigator
First posted
May 11, 2022
Start date
Sep 1, 2021
Primary completion
Sep 2022 (estimated)
Completion
Sep 2022 (estimated)
Last update
May 11, 2022

Study contacts

Dita Aditianingsih, Dr
study chair · Dr Cipto Mangunkusumo Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in May 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion